Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Boehringer Ingelheim
Harvard Business School
Federal Trade Commission
Medtronic
Cipla
Novartis
US Department of Justice
UBS
Cerilliant

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,806,265

« Back to Dashboard

Which drugs does patent 7,806,265 protect, and when does it expire?

Patent 7,806,265 protects MITOSOL and is included in one NDA.

This patent has nine patent family members in five countries.
Summary for Patent: 7,806,265
Title:Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application
Abstract: An apparatus for preparing a pharmaceutical for transient application includes a tray having a sealed compartment, a vial of an ophthalmic formulation of mitomycin-C, a diluent carrier containing sterilized water, and a syringe that are all contained together in a single package. The component parts of the apparatus are used together to reconstitute the contents of the vial with the water in the diluent carrier, and then draw the reconstituted drug into the sealed compartment of the tray by a suction force produced by the syringe. In the tray compartment, the reconstituted drug is absorbed in an absorbent pad. The tray is opened to remove the pad and the absorbed drug from the tray compartment for use of the pad in transient application of the drug.
Inventor(s): Timm; Edward J. (Cumming, GA)
Assignee: Mobius Therapeutics, LLC (St. Louis, MO)
Application Number:11/484,998
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Device;

Drugs Protected by US Patent 7,806,265

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Mobius Therap MITOSOL mitomycin FOR SOLUTION;TOPICAL 022572-001 Feb 7, 2012 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 7,806,265

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,186,511 Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application ➤ Subscribe
9,205,075 Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application ➤ Subscribe
9,649,428 Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application ➤ Subscribe
9,539,241 Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,806,265

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2007272514 ➤ Subscribe
Canada 2659314 ➤ Subscribe
European Patent Office 2046653 ➤ Subscribe
European Patent Office 3175843 ➤ Subscribe
Japan 2009543608 ➤ Subscribe
Japan 2014097399 ➤ Subscribe
Japan 5448071 ➤ Subscribe
Japan 5670546 ➤ Subscribe
World Intellectual Property Organization (WIPO) 2008008802 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Boehringer Ingelheim
Chubb
Harvard Business School
Cipla
US Army
McKinsey
Accenture
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot